Invagen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INVAGEN PHARMS, and what generic and branded alternatives to INVAGEN PHARMS drugs are available?
INVAGEN PHARMS has sixty-one approved drugs.
There is one tentative approval on INVAGEN PHARMS drugs.
Drugs and US Patents for Invagen Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Invagen Pharms | PENICILLAMINE | penicillamine | CAPSULE;ORAL | 213293-001 | Aug 19, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Invagen Pharms | LANTHANUM CARBONATE | lanthanum carbonate | TABLET, CHEWABLE;ORAL | 206868-003 | Jan 24, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Invagen Pharms | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 090935-001 | May 25, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Invagen Pharms | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 206556-002 | Aug 26, 2016 | AB3 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Invagen Pharms | CITALOPRAM HYDROBROMIDE | citalopram hydrobromide | TABLET;ORAL | 077534-001 | Oct 3, 2006 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Invagen Pharms | TOPIRAMATE | topiramate | TABLET;ORAL | 079162-004 | Mar 27, 2009 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Invagen Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Invagen Pharms | LEUPROLIDE ACETATE FOR DEPOT SUSPENSION | leuprolide acetate | FOR SUSPENSION;INTRAMUSCULAR | 205054-001 | Aug 28, 2018 | 9,789,064 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.